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Abstract
Microbial pathogenicity in Staphylococcus aureus is a com-
plex process involving a number of virulence genes that are
regulated by global regulatory systems including sar and
agr. To evaluate the roles of these two loci in virulence, we
constructed sar-lagr- mutants of strains RN6390 and
RN450 and compared their phenotypic profiles to the corre-
sponding single sar- and agr- mutants and parents. The
secretion of all hemolysins was absent in the sar-lagr- mu-
tants while residual 8-hemolysin activity remained in single
agr- mutants. The fibronectin binding capacity was signifi-
cantly diminished in both single sar- mutants and double
mutants when compared with parents while the reduction
in fibrinogen binding capacity in the double mutants was
modest. In the rabbit endocarditis model, there was a sig-
nificant decrease in both infectivity rates and intravegeta-
tion bacterial densities with the double mutant as compared
to the parent (RN6390) at 10'-10' CFU inocula despite com-
parable levels of early bacteremia among various challenge
groups. Notably, fewer bacteria in the double mutant group
adhered to valvular vegetations at 30 min after challenge
(106 CFU) than the parent group. These studies suggest that
both the sar and agr loci are involved in initial valvular
adherence, intravegetation persistence and multiplication of
S. aureus in endocarditis. (J. Clin. Invest. 1994. 94:1815-
1822.) Key words: Staphylococcus aureus * regulation of
gene expression * endocarditis * bacterial adhesion * staphy-
lococcal infections
Introduction
Septicemia due to Staphylococcus aureus is often the conse-
quence of a local infection that has gained access to the blood-
stream (1). Once the bacteria enter the bloodstream, patients
are at risk of developing endocarditis and other life-threatening
metastatic complications (1). Although the use of newer antimi-
crobial agents has initially controlled some of these infections,
the recent emergence of multiple-drug resistance in S. aureus
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has made many currently available antimicrobial agents (includ-
ing fluoroquinolones) ineffective, thereby posing an important
public health problem (2, 3). Thus, there is an urgent need for
alternative approaches in the treatment of S. aureus infections.
One potentially effective mechanism for dealing with the
emergence of antibiotic resistance among S. aureus strains is
the development of safe and effective vaccines. However, ex-
perimental data justifying a direct vaccine strategy are presently
lacking. An alternative approach is to consider targeting regula-
tory loci that are involved in the control and expression of
potential virulence determinants (e.g., hemolysins and fibrino-
gen and fibronectin binding proteins) (4-7). From this perspec-
tive, an understanding of the genetic control apparatus and their
regulatory pathways may allow the design of novel antimicro-
bial or pharmacologic agents to control this virulent patho-
gen (8).
Postexponential phase expression in bacteria is generally
governed by global regulatory systems in which a common
regulator controls the activities of several unlinked genes (9,
10). Many exoproteins normally synthesized and secreted dur-
ing the postexponential phase in S. aureus are virulence factors
(4). In contrast, synthesis of a number of surface proteins (e.g.,
protein A, coagulase, and fibronectin binding proteins) that
clearly play a role in staphylococcal infections is repressed
postexponentially (4, 9). The regulation of virulence determi-
nants and other exoprotein genes in S. aureus involves at least
three global regulatory systems including agr, xpr, and sar (9,
11, 12). The agr locus controls production of extracellular and
cell wall proteins that appear to play a role in virulence (e.g.,
hemolysins, coagulase, and protein A). The xpr locus, like that
of agr, also positively regulates exoprotein synthesis (11).
Smeltzer et al. (11) reported that two sets of agr- and xpr-
mutants with different genetic backgrounds were less lethal
than their corresponding parents in a mouse peritonitis model;
however, a very high challenging inoculum (109-1010 CFU)
was required for lethality in this study.
We recently identified by Tn917LTV1 insertional mutagen-
esis an additional regulatory locus, designated sar, in S. aureus
(12). Inactivation of this locus has led to decreased expression
of several exoproteins (hemolysins) and cell wall proteins (fi-
brinogen and fibronectin binding protein) that are potential viru-
lence determinants in experimental infections (4, 12). In a rabbit
endocarditis model, we have previously shown that there
was a significant decrease in infectivity rates in a sar- mu-
tant at 03-_104 CFU inocula when compared to the parental
strain (13).
To evaluate the contributory roles of both sar and agr loci
in staphylococcal virulence, we have constructed sar-/agr- mu-
tants of RN6390 and RN450 and compared their in vitro proper-
ties to the wild-type parent and single isogenic mutants. In
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studies with RN6390-related strains in the rabbit endocarditis
model, there was a significant reduction in infectivity rates
across a broad range of challenging inocula (103- 106 CFU)
with the double mutant when compared to the corresponding
sar'/agr' (parent) strain. These results suggest that both loci
are involved in the initiation and persistence of S. aureus infec-
tion in the fibrin-platelet-endothelial matrix in endocardial vege-
tations.
Methods
Bacterial strains, plasmids, DNA probes, and phage. The bacterial
strains, plasmids and DNA probes used in this study are listed in Table
I. Phage 411 was used as a transducing phage for RN6390 and RN450.
Media and antibiotics. CYGP, 0.3GL, and Brain-Heart-Infusion
(Difco Laboratories Inc., Detroit, MI) were used for the growth of
bacteria (12). Antibiotics were used at the following concentrations:
erythromycin at 10 jig/ml and tetracycline at 5 jig/ml.
Transduction. Phage 411 was used to prepare lysates of strain
RN6911 (14) which is an agr- mutant of parental strain RN6390 (12).
The phage lysate was used to infect sar- mutants R and A (15) derived
from strains RN6390 and RN450, respectively, at a low multiplicity of
infection (phage to recipient ratio = 1:10). Transductants carrying the
double mutations were selected on 0.3 GL agar containing both erythro-
mycin and tetracycline. The 411 lysate of RN691 1 was also used to
infect strain RN450 to obtain tetR transductants carrying the agr mutation
alone.
Phenotypic characterization. For phenotypic characterization, the
measurements included a; ,3; and 5-hemolysin production on sheep and
rabbit erythrocyte agar as previously described (16), lipase production
as measured on 1% Tween 20 agar plates (12), fibronectin binding
capacity as assayed by 251I-labeled fibronectin binding (17), and fibrino-
gen binding capacity as determined by 125I-labeled fibrinogen bind-
ing (18).
To determine whether the double mutant differed from either the
parent or single isogenic mutants in other phenotypic traits likely to be
important in endocarditis pathogenesis, we studied the comparative in
vitro ability of these strains to: (a) adhere to platelets as measured by
flow cytometry (19, 20); and (b) resist the bactericidal action of platelet
microbicidal protein (PMP)' (21).
For platelet adherence assays, rabbit whole blood was collected
into polypropylene tubes containing sodium citrate (5:1) and 1 pg/ml
prostaglandin E1 (PGEI) (Sigma Chemical Co., St. Louis, MO) to miti-
gate platelet activation. Platelets were isolated by centrifugation (150 g
for 10 min) and labeled externally with P2 (2.5 Ag/ml), an FITC-conju-
gated monoclonal antibody against CD41 (AMAC, Westbrook, ME),
or internally labeled with 5 jiM 5-chloromethylfluorescein diacetate
(CMFDA; Molecular Probes, Eugene, OR). After 1 h of incubation, the
platelets were washed and suspended in Tyrode's solution as previously
described (22). To label bacteria, overnight cultures of each strain were
washed in Tris-EDTA-NaCl buffer (0.05 M Tris-HCl with 0.1 M NaCl
and 0.02 M EDTA, pH 7.2) and labeled for 3 h with Hoechst 33342
dye (25 1ig/ml; Polysciences, Warrington, PA), a DNA-binding fluoro-
chrome (22). Adherence studies were performed at 20°C by mixing
bacteria and platelets in Tyrode's salts solution (Sigma Chemical Co.)
at a bacterial/platelet ratio of 10:1. One minute after mixing, the suspen-
sions were analyzed using a FACSta?'P" (Becton Dickinson, San Jose,
CA) cytofluorograph, using predetermined combinations of argon lasers,
excitatory wavelengths, and appropriate filters (19, 22). The percentage
of bacteria adhering to platelets was determined as previously de-
scribed (19).
For the second assay, PMP was prepared from thrombin-stimulated
platelet-rich plasma and assayed for bioactivity (U/ml) as previously
1. Abbreviation used in this paper: PMP, platelet microbicidal protein.
described (21). PMP was added to washed bacterial suspensions in low
protein-binding microtiter plates (Corning Glassworks, Corning, NY)
to achieve a final PMP concentration of 100 U/ml and a final bacterial
inoculum of - 103 CFU/ml. After 2 h of incubation at 370C, 20-pl
aliquots were processed for quantitative culture as described previously
(21). The percent bacterial survival was calculated for each S. aureus
strain. Bacillus subtilis (ATCC 6633), a highly PMP-susceptible strain,
served as a positive control for PMP bioactivity while wells containing
the organism plus minimal essential medium (Irvine Scientific, Santa
Ana, CA) alone were used as negative controls (23).
Southern blot hybridization. S. aureus DNA was prepared from
lysostaphin-lysed cells as described (12). Chromosomal DNA was di-
gested with selected restriction enzymes (New England BioLabs, Bev-
erly, MA), transferred onto Hybond N' membrane (Amersharn, Arling-
ton Heights, IL) and hybridized at 650C with probes labeled with 32p
by the random-primed method (Ready to Go Labeling Kit; Pharmacia
Fine Chemicals, Piscataway, NJ) or the nick translation method (Nick
Translation Kit; Boehringer Mannheim, Indianapolis, IN). After hybrid-
ization, the membrane was washed with SSPE (10 mM NaH2PO4, 150
mM NaCl, 1 mM EDTA, pH 7.4) according to the membrane manufac-
turer's instructions (12) and autoradiographed with an intensifying
screen at -70'C.
Northern blot hybridization. S. aureus RNA was prepared using a
modification of the method of Kornblum et al. (24) as previously de-
scribed (15). For Northern blots, equal volumes (7.5 1tl) ofRNA samples
extracted from an equivalent number of bacterial cells were electropho-
resed through a 1.5% agarose-0.66 M formaldehyde gel in MOPS run-
ning buffer as described (15). The intensity of the 23 S and 16 S
ribosomal RNA bands stained with ethidium bromide was verified to
be equivalent among all samples before transfer. RNA was transferred
to Hybond N (Amersham), cross-linked with UV light, allowed to hy-
bridize with a 32P-labeled gel purified DNA probes (25) in 50% for-
mamide at 420C overnight, washed, and autoradiographed as de-
scribed (15).
Animal model of endocarditis. All bacterial strains were grown in
brain-heart infusion broth at 370C overnight with rotation (30 rpm)
supplemented with appropriate antibiotics if necessary. In preliminary
studies, it was determined that the growth rates of parental and mutant
strains were almost identical both in the presence and absence of antibi-
otics over a 24-h period. In our previous study with a sar- mutant (13),
we established that incorporation of antibiotics into the overnight growth
media did not influence the ability of the strain to induce experimental
endocarditis. Overnight cultures were harvested by centrifugation (2,000
g for 10 min), washed twice in sterile normal saline and resuspended
in saline to an OD62Nm of 1.6 (- 1 x 109 CFU/ml). This bacterial
suspension was serially diluted in saline to - 103-106 CFU/ml. Each
dilution was confirmed by quantitative culture on blood agar plates.
Endocarditis on the aortic valve of New Zealand White rabbits (2-
2.5 kg) was induced by a modification of the method of Durack and
Beeson (26). In brief, rabbits were anesthetized by intramuscular injec-
tion of ketamine chloride (Aveco Inc., Fort Dodge, IA) at 35 mg/kg
and xylazine (Mobay Corp., Shawnee, KS) at 1.5 mg/kg. A polyethylene
catheter with an internal diameter of 0.86 mm (Becton Dickinson, Cor-
keysvilie, MD) was introduced into the left ventricle via the right carotid
artery to produce sterile thrombotic endocarditis. To induce endocarditis,
groups of - 10-15 animals each were challenged intravenously at 48
h after catheterization with various inocula of different bacterial strains
(103-106 CFU). Catheters remained in place until animals were sacri-
ficed by lethal injection of sodium pentobarbital (100 mg/kg) at 48 h
after bacterial challenge. Animals with macroscopic valvular vegetations
and proper catheter placement were analyzed for data in this study. At
time of sacrifice, aortic valves and left ventricular vegetations were
removed, pooled, weighed, homogenized in 0.5 ml of normal saline
and quantitatively cultured in antibiotic-free medium (for all strains),
erythromycin-containing medium (for mutant R and I), tetracycline-
containing medium (for RN6911 and mutant I) or medium containing
both antibiotics (double mutant). Animals with negative cultures of
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-Figure 1. Southern blots of
transductants from sar- mutants
R and A. (A) HindIII chromo-
somal digests probed with
pMVN6, a pUC8 plasmid car-
rying a 2.9-kb fragment of tetM;
(B) NcoI chromosomal digests
probed with a 513-bp PCR frag-
ment of agrA gene; (C) EcoRI
chromosomal digests probed
with a 1.5-kb HindIII fragment
of pLTVlI.
their undiluted vegetation homogenates were considered to have had no
induction of endocarditis at a particular inoculum (13).
To determine the relative ability of different bacterial strains to
adhere to sterile endocardial vegetations early after intravenous chal-
lenge, separate groups of 6-8 catheterized rabbits each were challenged
intravenously at 48 h after catheterization with 104, 105, or 106 CFU of
either the parent or mutant strains. Thirty minutes after bacterial injec-
tion, all animals were sacrificed, their hearts opened, and all visible left-
sided vegetations from each animal excised and pooled. Each vegetation
pool was washed gently with PBS to remove any surface blood and
nonadherent bacterial cells, placed in 0.5 ml of PBS, and homogenized
in a tissue grinder. To account for any bacterial cells that might have
adhered to the tissue grinder or tube during homogenization, the appara-
tus were washed with 1 ml of PBS. The vegetation homogenate together
with the wash from each individual animal were quantitatively cultured
into antibiotic-free as well as antibiotic-selective brain-heart infusion
agar based on the infecting strain.
To assure that any observed differences in valvular adherence and
endocarditis induction rates among strains were not due to a disparity
in the level of early bacteremias, quantitative blood cultures were ob-
tained in a separate study at 1-min post-iv inoculations with each bacte-
rial strain at 103-106 CFU.
Statistical analysis. The Fisher's exact test was used to compare
the induction rates of endocarditis among strains. The mean bacterial
vegetation densities and early adherence were evaluated by the Kruskal-
Wallis analysis of variance for nonparametric data with Tukey post-hoc
analysis for multiple comparisons. The Student t test was used to com-
pare the binding of radiolabeled fibrinogen and fibronectin to different
isolates. P valves s 0.05 were considered significant.
Results
Transduction of the agr- genotype into sar- mutants R and A.
Transduction was used to transfer the agr- genotype from agr
mutant RN6911 into sar- mutants R and A derived from
RN6390 and RN450, respectively. Southern blots of chromo-
somal DNA from transductants (mutants AD and I) digested
with HindIII, EcoRI, or NcoI revealed a hybridization pattern
consistent with the transfer of the agr- genotype (Fig. 1). More
specifically, the double sar-lagr- mutants hybridized with tetM
but not the agr probe (Fig. 1, A and B). Notably, two bands
hybridized to the probe that comprises of tetM cloned into
pUC8. The upper band represented hybridization of the pUC8
probe with the E. coli-derived portion of inserted transposon
Tn917LTV1 while the lower hybridizing band corresponded to
that of tetM (Fig. 1 A). This pattern of hybridization of the
double mutants with tetM and agr probes was similar to that
of the agr mutant RN6911 in which the entire agr locus had
been replaced by the tetM gene (Fig. 1, A and B). To verify the
maintenance of the Tn9J7LTV1 insertion in the double mutants,
Southern blots of chromosomal DNA from these transductants
digested with EcoRI was performed. Our results indicated that
a single EcoRI fragment from these double mutants hybridized
with a 1.5-kb HindIll fragment of Tn917 as a probe (Fig. 1 C).
This hybridizing pattern is analogous to that seen with original
sar- mutant 1 ID2, thus suggesting that the location of the
Tn917LTV1 insert in these double mutants was identical to that
of mutant 1I1D2 (Fig. 1 C).
We have also transduced the agr- genotype from RN6911
into RN450 to obtain sar+/agr- mutants. At least 10 tetR trans-
ductants were found one of which (mutant D) is listed in Table
I. The results of Southern blot studies of these transductants
with tetM and agr probes were similar to that of RN6911 (data
not shown), thus implying displacement of the agr locus by the
tetM gene in these transductants.
Northern blot analysis of the sar+/agr- and sar-/agr- mu-
tants with both agrA and hid probes confirmed that transcription
of these genes did not occur in these strains (data not shown).
Similarly, no transcripts were detected in the sar-/agr+ and
sar-/agr- strains when total cellular RNA immobilized on ny-
lon membranes were probed with the sarA gene probe (data
not shown).
Phenotypic characterization of sar-/agr- mutants in com-
parison to sar-/agr+, sar+/agr-, and sar+/agr+ (parent) strains.
Two sets of mutants were evaluated for phenotypic alterations
(Table II). Compared with parental strain RN6390, no hemoly-
sins (a, ,6, or 6) were detected in the corresponding sar-lagr-
mutant. In contrast, a small but detectable amount of 63-hemoly-
sin was secreted by both single sar- and agr- mutants (mutant
R and RN691 1, respectively). In assays with RN450-related
strains, the secretion of 6 hemolysin was absent in both sar-/
agr- and sar-lagr+ mutants but present in the sar+lagr- mutant.
Northern blot analysis of one set of strains (RN6390, RN691 1,
sar- mutant R and double mutant I) with a- and 68-hemolysin
probes revealed almost complete abolition of these exoprotein
gene transcripts in the double mutant (Fig. 2, A and B). In
concordance with our previous findings (15) and that of Vandes-
desh et al. (14), a significant downregulation of these transcripts
in the sar-/agr+ (mutant R) and sar+/agr- (RN691 1) mutants
was also observed.
The effect of these mutations on cell-bound proteins was
also studied. The fibronectin binding capacity was significantly
reduced in both double mutants and single sar- mutants (Table
II) when compared with their respective parents. Similar to the
results reported by Kornblum et al. (9), the binding of radiola-
beled fibronectin was increased in both sar+/agr- mutants. The
ability to bind fibrinogen was diminished in both double mu-
tants, but the magnitude of the reduction, albeit statistically
significant, was more substantial in mutant AD than mutant I.
Consistent with our previous studies (15), there was a modest
decline in the ability to bind fibrinogen as a result of the sar
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Table L Bacterial Strains, Plasmids, and DNA Probes
Types References Comments
Bacterial strains
S. aureus
DB 12 A wild-type blood isolate that is the parent of the original sar- mutant 1D2.
11D2 12 An isogenic mutant of strain DB with a sar::Tn9l7LTV1 mutation
RN6390 40 A prototypic strain that maintains its hemolytic pattern when propagated on sheep erythrocyte agar.
Mutant R 15 An isogenic mutant of RN6390 carrying a sar.:Tn9l7LTVl mutation.
RN6911 14 An isogenic mutant of RN6390 with an agr::getM mutation.
Mutant I This study A derivative of RN6390 carrying both sar::Tn9J7LTV1 and agr::tetM mutations.
RN450 40 A prototypic strain, which is a derivative of NCTC 8325 cured of prophages, secretes /3 hemolysin
but not a hemolysin.
Mutant A 15 An isogenic mutant of RN450 with a sar.:Tn9J7LTVI mutation.
Mutant D This study An isogenic mutant of RN450 with a agr::tetM mutation.
Mutant AD This study A double mutant of RN450 with both sar::Tn917LTVl and agr.:tetM mutations.
E. coli with plasmids
DU5384 41 An E. coli strain carrying a pBR322 plasmid with a 3-kb EcoRI-HindIII fragment of the a-hemolysin
gene to be gel-purified to be used as a probe.
RN6929 42 JM109 containing a pBluescript plasmid with a 2.2-kb Clal fragment of the /3-hemolysin gene which
was gel-purified to be used as a probe.
DNA probes
pLTVl 12, 43 A derivative of Tn9J7 carrying a E. coli replicon. A 1.5-kb Hindu gel-purified fragment was used as
a probe.
pALC4 31 A shuttle plasmid (pSPT181) containing a 732-bp PCR fragment of sarA gene of RN6390.
pMVN6 44 A pUC8 plasmid carrying a 2.9-kb BamHI fragment of tetM.
hld probe This study A 51 1-bp PCR fragment of the RNAIII from nucleotides 1265-1775 based on published sequence
(9).
agrA probe This study A 513-bp PCR fragment of the agrA gene from nucleotides 3830-4342 (9).
Table II. Phenotypic Characterization of RN6390, RN450, and Their Corresponding sar/agr Mutants
Strains
RN6390 RN6911 Mutant R Mutant I RN450 Mutant D Mutant A Mutant AD
Phenotypes* sar+lagr+ sar+/agr7 sar-lagr+ sar-lagr- sar+lagr+ sar+lagr- sar-lagr+ sar-lagr-
a-Hemolysin ++- - - - - - -
,B-Hemolysin ++ + + - + +
6-Hemolysin ++ - - - +--
Lipase + - + +
Fibronectin binding
protein' 3314±35 4059±117 2636±80 2809±60 15221±671 26852±691 4874±192 4909±611
Fibrinogen binding
protein11 5694±70 5427±314 5156±94 5118±118 6139±119 5326±103 3463±449 3094±97
Susceptibility to PMP (%
survival) 0% 0% 0% 1.3%
Platelet binding by FACS
(% bound)1 61.7±39.7 57.3±42 69.1±26.6 72.8±26.1
* + +, strong producer; +, moderate producer; +/-, very weak producer; -, non producer. * The expression of a-hemolysin in these strains was
also confirmed by immunoblots of extracellular proteins probed with affinity purified anti-a-hemolysin antibody (Toxin Technology, Sarasota, FL).
tData are presented as cpm of l"I-fibronectin bound to 109 CFU. Values are given as mean+SEM (n = 4). The reduction in fibronectin binding
of double mutants I and AD in comparison with the respective parental strains is statistically significant (P 5 0.009 and 0.001 for mutant I and
AD, respectively; t test). The augmentation in fibronectin binding as a result of the agr mutation alone (RN6911 and mutant D) was also significant
when compared to the respective parents (P - 0.004 and 0.001 for RN6911 and mutant D, respectively; t test). 11 Data are given as cpm of
12'I-fibrinogen bound to 109 CFU and are reported as the mean±SEM (n = 4). The binding of radiolabeled fibrinogen to double mutants I and AD
was lower than that of the respective parental strain (P 5 0.023 and 0.0001 for mutants I and AD, respectively; t test). Similarly, sarf mutant A
bound less radiolabeled fibrinogen than parent strain RN450 (P 5 0.008). 1 Platelets labeled with P2 or CMFDA were bound comparably by all
strains.
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Figure 2. Northern blots of a- (A) and /B- (B) hemolysin transcripts of
parental strain (RN6390) and the corresponding sarlagr mutants. The
positive control in A is a pBR322 plasmid carrying a 3-kb EcoRI-
HindII fragment of the a-hemolysin gene (41). In B, the positive control
is a pBluescript plasmid with a 2.2-kb Clal fragment of the /3-hemolysin
gene (42).
mutation in both strains (see mutants R and A in Table II).
However, the effect of the agr mutation alone on fibrinogen
binding capacity was more variable, with one resulting in a
slight reduction (mutant D) while the other one remaining un-
changed (RN691 1).
In preliminary studies, it was determined that strain RN6390
was virulent in the animal endocarditis model (see below).
Based on this finding, we evaluated other phenotypic traits in
RN6390 and its corresponding mutants that are likely to be
important in the pathogenesis of endocarditis, including suscep-
tibility to PMP (19) and the ability to bind platelets (27, 28).
As seen in Table H, all strains were very susceptible to the
killing action of PMP. After exposure to PMP at 100 U/ml for
120 min, the mean survival among these strains was between
0 and 1.3%. Likewise, the ability to bind platelets as assayed
by FACS was similar among all strains studied (Table H).
Animal model of endocarditis. In pilot studies, it was deter-
mined that the ID,0 for parental strain RN6390 was between
103 and 104 CFU. The induction rates for endocarditis with
parent RN6390 and its corresponding mutants were evaluated
at various intravenous challenge inocula between 103 and 106
CFU, thereby encompassing the IDgo for the parental strain
(Table HI). At all four challenge inocula, the sar-lagr- double
mutant caused substantially lower induction rates of endocardi-
tis than sar+/agr+ parent (RN6390) (0, 0, 28, and 50% vs 90,
70, 100, and 100% at 103_106 CFU with P < 0.00006, 0.0015,
0.002, and 0.03, respectively). Similar to our previously re-
ported data on parent strain DB and its isogenic sar-lagr+ mu-
tant (13), intravenous challenge with the sar-lagr+ mutant R
also resulted in reduced endocarditis induction rates as com-
pared with the parent strain at the two lower challenge inocula
(O and 11% vs 90 and 70% at 103-104 CFU with P values
< 0.0001 and 0.015, respectively). In contrast, the difference
in induction rates between the sar'lagr- (RN6911) strain and
its sar'lagr+ parent (RN6390) was only significant at the lowest
inoculum (40 vs 90% at 103 CFU; P _ 0.03). Notably, there
were no statistical differences between the induction rates of
sar-lagr+ versus sar+/agr- mutants at any challenge inocula.
The vegetation bacterial densities in different animal groups
were parallel-plated onto antibiotic-containing as well as antibi-
otic-free media. Our results indicated that there were no differ-
ences in quantitative recovery of bacteria between these two
Table II. The Induction of Endocarditis in a Rabbit Model with
sar+/agr' (RN6390), sarl/agr-, sar-lagr', and sar-lagr- Strains
Strains
RN6390 RN6911 Mutant R Mutant I
(sar'lagr') (sar'/agr-) (sar-lagr') (sar-lagr-)
103CFU 9/10 4/10* 0/10* 0/10'
104 CFU 7/10 4/11 1/9* 0/10§
105 CFU 11/11 8/10 10/11 2/7§
106 CFU 9/9 8/11 9/12 4/8§
At 48 h after catheterization, bacteria were injected directly into the
marginal ear veins. All rabbits were sacrificed for morphological exami-
nation and valvular cultures at 48 h after bacterial challenge. Values
aregiven as numberwithendocarditis/total numberinthegroup. * Statis-
tically significantly when compared with sar'lagr' parental strain (P
c 0.03; Fisher Exact test). t When compared with the parental strain,
induction rates are significant with the P values < 0.0001 and 0.015 at
103 and 104 inocula, respectively. § Induction rates are significantly
lower than that of the parental strain at all inocula (P values of 0.00006,
0.0015, 0.002, and 0.03 at 103- 106 CFU, respectively).
plating methods. As shown in Fig. 3, animals challenged with
the double sar-lagr- mutant had significantly lower vegetation
densities as compared with the sar'/agr' parent at all challenge
inocula. At the two higher inocula (105- 106), challenge with
the sar-lagr' strain yielded lower bacterial densities in aortic
vegetations than the sar'/agr' parent. Although the mean bacte-
rial vegetation densities achievable with the sar+lagr- mutant
were lower than the parent at higher challenge inocula (105-
106 CFU), they did not reach statistical significance.
To verify the stability of the sar and agr mutations in mutant
strains after animal passage, chromosomal DNA of sar'lagr+
(parent), sar+/agr-, sar-/agr+, and sar-/agr- colonies isolated
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Figure 3. Bacterial vegetation densities of parental strain RN6390 vs
three sarlagr mutants. Values are given as mean values±SD obtained
from 8-10 animals in each group (sar'lagr+, sar+/agr-, sar-lagr+, and
sar-/agr-). The analyzed statistical data are as follows: 105 CFU +/+
vs -/- (P ' 0.0001), +/+ vs -/+ (P C 0.05); 106 CFU +/+ vs -/
- (P - 0.05), +/+ vs -/+ (P - 0.05). * The vegetation cultures in
these animal groups were negative.
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Figure 4. Relative bacterial adherence of parent (RN6390) vs three sari
agr mutants to aortic valvular vegetations. These are presented as total
number of organisms adhering at 30 min post-iv challenge. Values are
given as mean±SD obtained from 6-8 animals in each bacterial strain
group. *The P value in early valvular adherence between sar'Iagr'
parent and sar-lagr- double mutant is < 0.01.
from cultured vegetations (at least six each) were digested with
EcoRI, NcoI, or HindIII and probed with 32P-labeled agrA, hid,
tetM, Tn917, and sarA probes. In each instance, the colonies
harvested from the vegetations had hybridization patterns identi-
cal to those of the respective infecting strains isolated before
animal passage (data not shown as they are similar to those in
Fig. 1). These data indicated that the mutations remained stable
in vivo.
Determination of early adherence to sterile valvular vegeta-
tions. To determine if the above disparities in endocarditis in-
duction rates were attributable to differences in early valvular
adherence of bacteria, we sacrificed groups of catheterized ani-
mals 30 min after intravenous challenge to determine the total
number of CFU binding to valvular vegetations. At lower inoc-
ula (103-105), the number of adherent bacteria for all strains
was too low to make a meaningful comparison. However, at a
higher challenge inoculum (106 CFU), the adherence of the
parental strain was significantly higher than that of the double
mutant (181±79 vs 18±8 CFU/vegetations, respectively; P
< 0.01) (Fig. 4). Notably, the adherence of single mutants was
also less than the parent strain, but these differences did not
reach statistical significance (e.g., P - 0.14 between sar'lagr-
and sar'lagr' strains).
To confirm that differences in early valve adherence were
not related to the level of bacteremia following intravenous
challenge, quantitative blood cultures were obtained to assay
for comparative bacterial clearance. Because our previous ob-
servations had confirmed that very few colonies (1-5 CFU)
could be isolated on blood culture at 30 min post-iv challenge
(13), only blood cultures at 1 min post-iv challenge were ob-
tained. At each of the tested inoculum (103- 106 CFU), there
were no significant differences in the mean quantitative counts
of post-challenge bacteremias among various groups at 1 min
after intravenous challenge.
Discussion
Microbial pathogenicity is a complex process that involves the
products of a number of genes many of which are virulence
determinants controlled by global regulatory systems. The agr
and sar loci in S. aureus are examples of two such regulatory
systems (9, 12). Northern blot analyses suggested that the sar
locus, like that of agr (14), positively regulates exoprotein gene
expression via transcriptional control (15). However, in contrast
to agr, the expression of selected cell wall proteins such as
fibronectin and fibrinogen binding proteins, which have been
shown to be potential adhesins to catheters and endothelium (5,
7, 29, 30), are downregulated in sar- mutants as compared with
parent strains (12, 15). We have also established in a previous
study that a sar- mutant was less virulent than the parent at
low challenge inocula (103 and I 04CFU) in the endocarditis
model (13). Because of the counter-regulatory effects of the
same set of cell-wall protein genes by sar and agr loci, the
current study was undertaken to examine the in vitro phenotypic
interactions as well as the net in vivo effects of these two loci
in a prototypical endovascular infection model (experimental
endocarditis).
Our detailed examination of the phenotypic characterization
of sar and agr mutants has yielded interesting insights into the
control of exoprotein expression. As expected from previous
studies (9, 15), the secretion of hemolysins was generally de-
creased in both sar'lagr- and sar-lagr' mutants derived from
RN6390. Based on our recent observation that the optimal tran-
scription of RNAII, which is the agr regulatory molecule that
controls exoprotein gene transcriptions (9), is dependent on an
intact sar locus (31), we speculate that the sar locus likely
regulates exoprotein gene expression via transcriptional control
of RNAIH. However, additional phenotypic analysis of the dou-
ble sar-/agr- mutant (mutant I in Table I) suggested that the
sar locus may also affect exoprotein genes independently of
agr. This is predicated upon the finding that a double mutant
does not secrete /3-hemolysin while single isogenic mutants do.
Additionally, the mild augmentation of lipase production in
sar-lagr+ strain (mutant R) in comparison with the parent
(RN6390) was completely abolished in the double mutant I.
Although the fibronectin binding capacity was increased in
sar+/agr- mutants (RN6911 and mutant D in Table II) as pre-
dicted (9), this capacity was reduced in the double mutants
(mutants I and AD) and single sar- mutants (mutants R and A)
as compared to their respective parents. However, the ability to
bind radiolabeled fibrinogen remained essentially unchanged in
sar'lagr- mutants. In contrast, the fibrinogen-binding capacity
of both double mutants decreased to a level similar to that of
sar-/agr+ strains, although the magnitude of the decrease was
much smaller in double mutant I. As a single mutation in the
sar or agr locus yields opposite effects in cell-wall protein
expression, these experimental observations on the double mu-
tants provide two potential insights into regulatory control of
cell-wall proteins. First, in distinction to the exoprotein control
in which the sar and agr loci are possibly elements operating
under the same regulatory pathway, these data suggested that
the mechanisms of cell-wall protein control by these two loci
are likely to be different from that of exoprotein genes. Second,
two theoretical possibilities can account for the cell wall protein
profile of the double mutant. One possibility is that both sar
and agr loci function within the same regulatory pathway in
which the agr and sar gene product(s) act as the repressor and
the activator, respectively, for cell wall protein target sequences.
In the case of a double mutant, a lack of a repressor (i.e., agr-)
does not result in an overexpression of cell-wall proteins in the
absence of an activator (i.e., sar-) of target sequences. The
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second possibility is that the sar and agr loci control the expres-
sion of cell wall proteins via different regulatory mechanisms
such that a malfunctioning sar locus, irrespective of the func-
tionality of the agr locus, will lead to downregulation of cell
wall proteins.
As inactivation of both sar and agr loci resulted in reduced
production of extracellular and cell wall proteins that are puta-
tive virulence determinants in S. aureus (5, 7), we evaluated
the net in vivo effect of a double mutant in a rabbit model of
endocarditis. Our data showed that the double mutant had a
lower capacity to induce endocarditis as compared to the parent
strain at all challenge inocula (Table HI). Moreover, the vegeta-
tion bacterial densities were markedly decreased in the double
mutant in comparison with the parent strain at all challenge
levels. In contrast, the sar-lagr' mutant induced endocarditis
at a significantly lower rate than the parent strain only at the
two lower challenge inocula (103-104 CFU). This induction
rate is in concordance with our previous studies in which a
different single sar- mutant (strain 11D2) had a lower induction
rate than the isogenic parent only at such challenge inocula
(13). Interestingly, the induction rate for sar'/agr- strain dif-
fered from the parent only at the 103 CFU inoculum. Although
the induction rates for single sar mutant were statistically equiv-
alent to those of the parent strain at the higher challenge inocula
(105-106 CFU), the mean vegetation bacterial densities were
substantially lower in the sar mutant group, but not in the agr
mutant group, when compared to the parental group at these
inocula (Fig. 3).
Differences in the ability of the double mutant and parental
strains to induce endocarditis as described here may be related
to potential perturbations in either of the two critical events
in the pathogenesis of endocarditis: initial adherence to sterile
vegetation and/or subsequent intravegetation bacterial propaga-
tion (26, 32). Within the matrices of the valvular vegetations,
fibrinogen, fibronectin, vitronectin, platelets, and released plate-
let proteins (e.g., thrombospondin) are commonly deposited (5,
7, 32). In addition, underlying extracellular matrix proteins,
such as collagen and laminin, may also be exposed as a result
of prior endothelial damage (33, 34). During the initial phase
of bacteremia, a combination of impaired fibronectin and fi-
brinogen binding may conceivably contribute to a reduction in
the number of initial adherence events at the vegetation surface
for the double mutant. Notably, this diminished capacity to
bind fibronectin and fibrinogen in the double mutant is likely
attributable to a mutation in the sar locus (Table II). This con-
cept is consistent with the experimental observation that at
higher inocula (105_-106 CFU), the bacterial vegetation densities
achievable by the single sar mutant, but not the single agr
mutant, were significantly lower than the parent despite compa-
rable induction rates (Fig. 3). Nevertheless, the possibility that
additional staphylococcal surface receptors such as those for
collagen, laminin and thrombospondin (35-37) may be in-
volved in adhesion cannot be entirely ruled out. Our data also
seem to minimize the role of platelets in accounting for the
differences in early adherence between the parent and mutant
strains since they bound equally well to platelets, and were
highly susceptible to platelet-microbicidal-protein-induced le-
thality in vitro.
After initial adherence to the vegetation surface, the eventual
establishment of infection is still dependent on the ability of the
microorganism to proliferate within the vegetations. As noted in
Fig. 3, both the single sar mutant and the double mutant
achieved lower intravegetation bacterial densities than the par-
ent. Whether this reduction in intravegetation bacterial densities
is due to a diminution in cytotoxin secretion (e.g., hemolysins)
and/or a decline in initial adhesion observed in these mutants
is not resolved in this study. Nevertheless, a-hemolysin, a pore-
forming cellular cytotoxin, has been shown to exhibit lethality
for platelets and endothelial cells (38, 39), two important com-
ponents of the vegetation in endocarditis (33). It is conceivable
that the absence ofa hemolysin in a mutant strain may adversely
affect its ability to persist within vegetation. Because very few,
if any, leukocytes are found within infected aortic vegetations
in both experimental and human endocarditis (33), any dissimi-
larity in cellular immune response between the parent vs the
mutant strains is unlikely to explain the observed differences
in induction rates or intravegetation bacterial densities. As these
two regulatory loci control the synthesis of a variety of extracel-
lular and cell wall proteins, our data would seem to support the
multifactorial nature involved in the pathogenesis of S. aureus
endocarditis.
Considerable efforts have been spent previously to single
out a specific virulence factor in the pathogenesis of S. aureus
endocarditis and other related intravascular infections. How-
ever, these experimental approaches have not been successful
in explaining the range of this organism's ability to induce and
propagate infections at a challenging inoculum found in similar
human infections (4, 7). For example, in experiments involving
inactivation of the fibronectin binding protein alone, the contrib-
utory role of this protein in endocarditis virulence is modest at
best even at a fairly high challenge inoculum (106 CFU) (7).
Based on these investigations, it appears that S. aureus may have
a wide arsenal of adhesins and toxins to facilitate adherence and
propagation within human valvular tissues. In this study, we
have shown that the sar and agr loci of S. aureus are important
regulatory elements in the expression of virulence determinants
necessary for the induction and propagation of intravegetation
growth in the animal model. Hence, it may be meaningful to
target these regulatory loci for the development of novel antimi-
crobial agents (e.g., designing a synthetic analog to block activa-
tion of virulence factors by the native sar gene products).
One of the genes (sarA) within the sar locus has recently
been cloned (31). Sequence analysis revealed an open reading
frame of 372 bp with a predicted mol wt of 14,718 D. Additional
studies indicated that this gene is necessary for the optimal
transcription of RNAIII (31). In this current study, there is
additional evidence to suggest that both agr-dependent and agr-
independent pathways are probably operational in the regulation
of virulence determinants in S. aureus. To our knowledge, this
is the first study that implicates both regulatory loci (i.e., sar and
agr) in early bacterial adherence, induction, and intravegetation
persistence in the pathogenesis of endocarditis. A detailed un-
derstanding of the entire sar locus and its mode of regulation
will provide insight into the molecular mechanisms of staphylo-
coccal pathogenesis and may uncover specific targets which
may be amenable to therapeutic intervention in S. aureus infec-
tions.
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